Evidence map›Paper›PMID 20859799›Full record

ReviewHandbook of experimental pharmacology2011

Methylxanthines, seizures, and excitotoxicity.

Detlev Boison

Abstract readReview
In one paragraph

Review in Handbook of experimental pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Neuroglia and brain energy metabolism.Handbook of clinical neurology · 2025
    Review
  3. Article
  4. Review
  5. Astrocyte-neuron circuits in epilepsy.Neurobiology of disease · 2023
    Review
  6. Article
  7. Review
  8. The metabolic basis of epilepsy.Nature reviews. Neurology · 2022
    Review
  9. Review
  10. Review
  11. Time to Recover From Daily Caffeine Intake.Frontiers in nutrition · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Detlev BoisonR.S. Dow Neurobiology Laboratories, Legacy Research, Portland, OR 97232, USA.
Legacy Health · US

Funding

Adenosine and schizophrenia: mechanisms and therapiesR01MH083973 · NIMH · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI BOISON, DETLEV · 2009 to 2015
$2.5M
Astrocyte dysfunction in epileptogenesis: the role of adenosineR01NS061844 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI BOISON, DETLEV · 2009 to 2013
$1.5M
Adenosine-releasing brain implants for epilepsy therapyR01NS058780 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI BOISON, DETLEV · 2008 to 2011
$1.2M
Adenosine kinase as novel therapeutic target to prevent acquired epilepsyR21NS057475 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI BOISON, DETLEV · 2008 to 2009
$379k
Adenosine kinase as therapeutic target to induce and maintain ischemic toleranceR21NS057538 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI BOISON, DETLEV · 2008 to 2009
$379k
NIMH NIH HHS R01 MH083973NIMH NIH HHS R01MH083973NINDS NIH HHS R01 NS058780NINDS NIH HHS R01NS058780NINDS NIH HHS R01 NS061844NINDS NIH HHS R01NS061844NINDS NIH HHS R21 NS057475NINDS NIH HHS R21NS057475-01NINDS NIH HHS R21 NS057538NINDS NIH HHS R21NS057538-01
6 · The paper itself

Abstract

Clinical evidence, in particular the wide use of theophylline as a bronchodilator, suggests that methylxanthines can cause seizures in patients without known underlying epilepsy. Theophylline is also known to be an added risk factor for seizure exacerbation in patients with epilepsy. The proconvulsant activity of methylxanthines can best be explained by their antagonizing the brain's own anticonvulsant adenosine. Recent evidence suggests that adenosine dysfunction is a pathological hallmark of epilepsy contributing to seizure generation and seizure spread. Conversely, adenosine augmentation therapies are effective in seizure suppression and prevention, whereas adenosine receptor antagonists such as methylxanthines generally exacerbate seizures. The impact of the methylxanthines caffeine and theophylline on seizures and excitotoxicity depends on timing, dose, and acute versus chronic use. New findings suggest a role of free radicals in theophylline-induced seizures, and adenosine-independent mechanisms for seizure generation have been proposed.

Indexed as

AdenosineAnimalsCaffeineHumansNeurotoxinsSeizuresTheophyllineXanthinesAdenosineCaffeinemethylxanthineNeurotoxinsTheophyllineXanthines

Identifiers

PMID20859799
PMCPMC2945384
OpenAlexW1585469811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.